Genetic Testing for Hypertriglyceridemia in Academic Lipid Clinics: Implications for Precision Medicine-Brief Report.
Matthew R DeshotelsTrevor D HadleyMendel RothAli M AghaVishnu Priya PulipatiAnne K NugentSalim S ViraniVijay NambiPatrick M MoriartyMichael H DavidsonChristie M BallantynePublished in: Arteriosclerosis, thrombosis, and vascular biology (2022)
The presence of both PV and high PRS significantly increased risk for very severe hypertriglyceridemia and acute pancreatitis, whereas PV or PRS alone only modestly increased risk. Genetic testing may help identify patients with hypertriglyceridemia who have the greatest risk for developing pancreatitis and may derive the greatest benefit from novel triglyceride-lowering therapies.